Table 2.
CV risk factors, characteristics, treatment received, and outcome in STEMI and NSTEMI ACS population.
| Characteristics | Overall ACS group | STEMI Group | NSTEMI/Unstable angina Group | p value |
|---|---|---|---|---|
| CV risk factors | ||||
| Self-reported hypertension | 2510 (43.4%) | 986 (37.1%) | 1524 (48.4%) | 0.001 |
| Self-reported diabetes | 1022 (17.7%) | 426 (16.1%) | 596 (19.0%) | 0.01 |
| Tobacco smokers (yes) % | 3658 (62.9%) | 1834 (69.7%) | 1823 (58.1%) | 0.0001 |
| Sedentary (yes) % | 1716 (29.7%) | 746 (28.3%) | 970 (30.9%) | 0.03 |
| BMI status | 4953 (24.0 ± 4.2) | 2230 (23.6 ± 4.1) | 2720 (24.4 ± 4.2) | 0.001 |
| BMI < 19.9 | 960 (18.4%) | 487 (20.7%) | 473 (16.5%) | 0.0001 |
| BMI 20–24.9 | 2411 (46.2%) | 1130 (48.0%) | 1281 (44.6%) | |
| BMI 25–29.9 | 1443 (27.6%) | 596 (25.3%) | 847 (29.5%) | |
| >30 | 408 (7.8%) | 140 (5.9%) | 268 (9.3%) | |
| Past H/O MI | 420 (7.2%) | 111 (4.2%) | 309 (9.8%) | 0.01 |
| Past H/O CABG | 52 (0.9%) | 7 (0.3%) | 45 (1.4%) | 0.01 |
| Past H/O PCI | 86 (1.5%) | 16 (0.6%) | 70 (2.2%) | 0.1 |
| Clinical characteristics | ||||
| Tachycardia | 985 (21.2%) | 482 (21.8%) | 503 (20.7%) | 0.02 |
| Hypotension | 577 (11.7%) | 383 (16.1%) | 245 (9.4%) | 0.001 |
| Killip Class 111/1V | 639 (11.0%) | 353 (13.4%) | 286 (9.0%) | 0.001 |
| A Fib | 5 (0.1%) | 3 (0.1%) | 2 (0.1%) | 0.5 |
| VT/VF | 50 (0.9%) | 30 (1.4%) | 20 (0.6%) | 0.04 |
| CHB | 246 (4.7%) | 145 (6.0%) | 101 (3.5%) | 0.0001 |
| Stress hyperglycemia (FBS > 126) | 1253 (46.3%) | 524 (44.1%) | 729 (48.1%) | 0.04 |
| Trop T positive | 2309 (40.3%) | 1133 (43.0%) | 1176 (37.8%) | |
| Treatment | ||||
| ASA | 5796 (100%) | 2634 (100%) | 3162 (100%) | |
| Clopidogrel | 5796 (100%) | 2634 (100%) | 3162 (100%) | |
| Statin | 5650 (97.3%) | 2579 (97.7%) | 3071 (97.1%) | 0.5 |
| B Blocker | 4706 (81.1%) | 2017 (76.4%) | 2689 (85.0%) | 0.001 |
| ACE inhibitor/ARB | 4716 (82.5%) | 2035 (78.5%) | 2681 (86.0%) | 0.01 |
| Thrombolytic therapy | 948 (16.3%) | 939 (35.6%) | 9 (0.3%) | |
| PCI | 37 (0.6%) | 25 (0.9%) | 12 (0.4%) | 0.01 |
| Outcome | ||||
| Death | 442 (7.6%) (6.9–8.3%) | 284 (10.8%) | 158 (5.0%) | 0.0001 |
| Bleeding | 55 (1.0%) | 33 (1.4%) | 22 (0.8% | 0.07 |
| Post-MI angina | 125 (2.4%) | 68 (2.8%) | 57 (2.0%) | 0.054 |
| Cardiogenic shock | 455 (10.2%) | 280 (13.0%) | 175 (7.6%) | 0.001 |